US 7772200
iRNA agents targeted to the Rho-A gene
granted A61PA61P21/00A61P25/00
Quick answer
US patent 7772200 (iRNA agents targeted to the Rho-A gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P21/00, A61P25/00, A61P25/18, A61P25/28